Does the United States Pharmacopeia throat introduce de-agglomeration of carrier-free powder from inhalers?
about
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder InhalerDe-agglomeration Effect of the US Pharmacopeia and Alberta Throats on Carrier-Based Powders in Commercial Inhalation Products.Potential of a cyclone prototype spacer to improve in vitro dry powder delivery.
P2860
Does the United States Pharmacopeia throat introduce de-agglomeration of carrier-free powder from inhalers?
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Does the United States Pharmac ...... ier-free powder from inhalers?
@ast
Does the United States Pharmac ...... ier-free powder from inhalers?
@en
Does the United States Pharmac ...... ier-free powder from inhalers?
@nl
type
label
Does the United States Pharmac ...... ier-free powder from inhalers?
@ast
Does the United States Pharmac ...... ier-free powder from inhalers?
@en
Does the United States Pharmac ...... ier-free powder from inhalers?
@nl
prefLabel
Does the United States Pharmac ...... ier-free powder from inhalers?
@ast
Does the United States Pharmac ...... ier-free powder from inhalers?
@en
Does the United States Pharmac ...... ier-free powder from inhalers?
@nl
P2093
P2860
P1476
Does the United States Pharmac ...... ier-free powder from inhalers?
@en
P2093
Judy Agnes Raper
Patricia Tang
Runyu Yang
Zhenbo Tong
P2860
P304
P356
10.1007/S11095-012-0703-Y
P577
2012-02-11T00:00:00Z